REG - Reckitt Benckiser Gp - Result of AGM

Reckitt BenckiserAnnouncement

02/05/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240502:nRSB0734Na&default-theme=true

RNS Number : 0734N  Reckitt Benckiser Group PLC  02 May 2024

2 May 2024

 

 

 

RESULT OF VOTING AT THE ANNUAL GENERAL MEETING OF

 

RECKITT BENCKISER GROUP PLC

 

HELD ON 2 MAY 2024

 

The resolutions proposed at the Annual General Meeting of Reckitt Benckiser
Group plc (the "Company") held earlier today were passed by the requisite
majority by poll. The results are set out below:

 

STATEMENT OF POLL

 

 RESOLUTION                                                                      VOTES FOR    %       VOTES AGAINST  %      VOTES CAST   % of ISC  VOTES WITHHELD

                                                                                                                                         Voted
 1. To receive and adopt the Annual Report and Financial Statements for the      539,972,033  99.96%  190,688        0.04%  540,162,721  73.34%    3,583,714
 year ended 31 December 2023
 2. To approve the Directors' Remuneration Report for the year ended 31          505,228,167  94.44%  2,9722,171     5.56%  534,950,338  72.63%    8,796,621
 December 2023
 3. To declare a final dividend of 115.9p per ordinary share for the year ended  542,589,211  99.89%  602,557        0.11%  543,191,768  73.75%    555,195
 31 December 2023
 4. To re-elect Andrew Bonfield as a Director                                    525,096,473  96.78%  17,484,868     3.22%  542,581,341  73.67%    1,165,063
 5. To re-elect Olivier Bohuon as a Director                                     541,898,922  99.77%  1,222,222      0.23%  543,121,144  73.74%    625,260
 6. To re-elect Margherita Della Valle as a Director                             541,782,308  99.75%  1,345,201      0.25%  543,127,509  73.74%    618,895
 7. To re-elect Mehmood Khan as a Director                                       541,896,969  99.77%  1,222,105      0.23%  543,119,074  73.74%    627,330
 8. To re-elect Elane Stock as a Director                                        541,906,747  99.78%  1,221,114      0.22%  543,127,861  73.74%    618,543
 9. To re-elect Mary Harris as a Director                                        531,282,468  97.82%  11,844,751     2.18%  543,127,219  73.74%    618,304
 10. To re-elect Sir Jeremy Darroch as a Director                                525,106,410  96.78%  1,7471,172     3.22%  542,577,582  73.67%    1,167,941
 11. To re-elect Tamara Ingram OBE as a Director                                 535,219,631  98.54%  7,905,378      1.46%  543,125,009  73.74%    620,514
 12. To elect Kris Licht as a Director                                           541,448,890  99.69%  1,687,432      0.31%  543,136,322  73.74%    609,759
 13. To elect Shannon Eisenhardt as a Director                                   539,393,231  99.31%  3,744,683      0.69%  543,137,914  73.74%    608,166
 14. To elect Marybeth Hays as a Director                                        542,734,929  99.93%  391,253        0.07%  543,126,182  73.74%    619,270
 15. To re-appoint KPMG LLP as Auditor of the Company                            539,232,950  99.28%  3,923,612      0.72%  543,156,562  73.74%    588,922
 16. To authorise the Audit Committee to determine the External Auditor's        542,974,582  99.96%  193,853        0.04%  543,168,435  73.75%    578,458
 remuneration
 17. To authorise the Company to make political donations                        530,938,374  98.84%  6,243,134      1.16%  537,181,508  72.93%    6,561,332
 18. To renew the Directors' authority to allot shares                           490,241,899  90.26%  52,902,997     9.74%  543,144,896  73.74%    601,114
 19. To renew the Directors' power to disapply pre-emption rights in respect of  533,501,185  98.45%  8,422,722      1.55%  541,923,907  73.58%    1,822,104
 up to 5% of issued share capital
 20. To authorise the Directors' power to disapply pre-emption rights in         530,928,997  97.95%  11,116,376     2.05%  542,045,373  73.59%    1,701,519
 respect of an additional 5% of issued share capital
 21. To renew the Company's authority to purchase its own shares                 539,302,694  99.40%  3,251,286      0.60%  542,553,980  73.66%    1,192,911
 22. That the Directors be authorised to call a general meeting, other than an   484,739,478  90.16%  52,898,472     9.84%  537,637,950  73.00%    6,108,941
 AGM, on 14 clear days' notice

 

 

 

Resolutions 19 to 22 are special resolutions.

 

A vote withheld is not a vote in law and is not counted in the calculation of
the proportion of votes for or against a resolution.

 

A copy of the above results will shortly be available on the Company's website
at www.reckitt.com (http://www.reckitt.com) .

 

In accordance with UK Listing Rule 9.6.2R a copy of all the resolutions passed
other than resolutions concerning ordinary business have been submitted to the
UK Listing Authority via the National Storage Mechanism and in due course will
be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

As at the close of business on 30 April 2024, the issued share capital of the
Company consisted of 736,535,179 ordinary shares of 10 pence each, 31,373,644
of which were held as treasury shares. Therefore, the total voting rights in
the Company as at that time were 705,161,535.

 

For further Information:

Catheryn O'Rourke

Company Secretary

Tel. 01753 217 800

 

103-105 Bath Road, Slough SL1 3UH

Registered in England and Wales, No. 6270876

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. We believe that access to the highest-quality hygiene,
wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and
trusted consumer brands in hygiene, health and nutrition, including Air Wick,
Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon,
Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet,
Woolite and more.

 

Every day, around 30 million Reckitt products are bought globally. We always
put consumers and people first, seek out new opportunities, strive for
excellence in all that we do and build shared success with all our partners.
We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our
collective energy to meet our ambitions of purpose-led brands, a healthier
planet and a fairer society.  Find out more, or get in touch with us at
www.reckitt.com (http://www.reckitt.com)

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSSFMEELSESI